

| 1. | verteporfin(Visudyne ) | ||
| 2. | pegaptanib ophthalmic(Macugen ) | ||
| 3. | ranibizumab ophthalmic(Lucentis ) | ||
Top
|
|||
|
VERTEPORFIN (VER te PORE fin) is used to treat macular degeneration. It is activated by light. This medication is given, then the eye(s) are treated with a laser light. This is called photodynamic therapy (PDT). This treatment results in a slowing...
|
|
Photosensitizing agent activated by low-intensity laser light; synthetic benzoporphyrin derivative.
|
|
PEGAPTANIB (peg AP ta nib) is a drug that is injected into the eye. It is used to treat macular degeneration. This treatment results in a slowing of the disease and helps to maintain vision. It is not a cure.
|
|
Polyethylene glycol (PEG)-conjugated, modified synthetic RNA oligonucleotide and aptamer; selective vascular endothelial growth factor (VEGF) antagonist.
|
|
RANIBIZUMAB (RA ni BIZ oo mab) is an injectable medicine for the eye. It is used to treat wet macular degeneration. This medicine helps to slow the disease and may help to maintain vision. It is not a cure.
|
|
Recombinant humanized immunoglobulin G 1 kappa (IgG 1 kappa) monoclonal antibody fragment; a vascular endothelial growth factor A (VEGF-A) antagonist.
|


